"We are very happy and the process was great. I am now working with eMagine to finalize the PowerPoint template and look forward to having a nice new template for our Corporate Roadshows.”
Taunton, MA (PRWEB) February 26, 2015
eMagine, the leading Digital Marketing Agency specializing in B2B, Technology and Healthcare, has partnered with advanced Bio-Pharma company Neuroscience Biosciences, Inc and is excited to announce the launch of their newly redesigned website, http://www.neurocrine.com. The website revamp came from a desire to update their out of date site design and content with a fresh new design that is able to respond to the multiple platforms that are now common to their visitors and users. As a solution, eMagine created an attractive and responsive design complete with animated clinical pipelines and user-friendly navigation that showcases the company’s initiative to discover and develop innovative and life-changing pharmaceuticals.
Vice President of IT and Operations for Neurocrine Biosciences, Inc. gladly stated, "In any technology project you have your challenges but working with Paul Bacon (VP of Web Development for eMagine) and his team we worked through each challenge as it came up. We are very happy and the process was great. I am now working with eMagine to finalize the PowerPoint template and look forward to having a nice new template for our Corporate Roadshows.”
In agreement, Bacon declared, “Neurocrine as a company and Bill Wilson specifically as my counterpart on the project, were such a pleasure to work with. I did my best to keep up with the intricacies of the Neurcrine business and Bill did his best to keep up with the website project. I believe we were able to lean on one another in that sense in order to produce a site we can both be proud of. It’s the essence of a great partnership and one eMagine is eager to maintain and grow over time.”
With impressive ongoing web design and SEO initiatives still in progress, Neurocrine’s new site focuses on their novel R&D platform utilizing advanced technologies to create treatments for neurological and endocrine-based diseases and disorders, creating an interactive experience that will allow users to follow their evolution into a fully integrated pharmaceutical company.
About Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. discovers and develops innovative and life-changing pharmaceuticals, in diseases with high unmet medical needs, through its novel R&D platform, focused on neurological and endocrine based diseases and disorders. The Company's two lead late-stage clinical programs are elagolix, a gonadotropin-releasing hormone antagonist for women's health that is partnered with AbbVie Inc., and a wholly owned vesicular monoamine transporter 2 inhibitor for the treatment of movement disorders. Neurocrine intends to maintain certain commercial rights to its VMAT2 inhibitor for evolution into a fully-integrated pharmaceutical company. Neurocrine Biosciences, Inc. news releases are available through the Company's website .
eMagine is the leading Web Design & Digital Marketing Agency for B2B, High-Tech Healthcare, Professional Services and Manufacturing. Tracing its origins to the dawn of the Internet age in 1995, eMagine’s services include, Web Design, SEO, Social Media, Branding and Web Support & Hosting. eMagine's helps clients achieve real business results from a 360 degree digital marketing effort. The company's blog (http://www.b2bwebstrategy.com/ ) provides industry thought leadership on the full spectrum of digital marketing. Join the conversation on Facebook, Twitter and LinkedIn. Further information may be found by visiting http://www.emagine.com or by calling 877-530-7993.